{"name":"Qilu Pharmaceutical (Hainan) Co., Ltd.","slug":"qilu-pharmaceutical-hainan-co-ltd","ticker":"","exchange":"","domain":"qiluhainan.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"QLG2198","genericName":"QLG2198","slug":"qlg2198","indication":"Type 2 diabetes","status":"phase_3"},{"name":"QLG2071","genericName":"QLG2071","slug":"qlg2071","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Aprepitant Injection","genericName":"Aprepitant Injection","slug":"aprepitant-injection","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"QLG2198","genericName":"QLG2198","slug":"qlg2198","phase":"phase_3","mechanism":"QLG2198 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Aprepitant Injection","genericName":"Aprepitant Injection","slug":"aprepitant-injection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"QLG2071","genericName":"QLG2071","slug":"qlg2071","phase":"phase_3","mechanism":"QLG2071 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQWFAtR3ZLdDQxVFhBWFdUWkV2cG9QY21uRzBoZWpyVGtzUmpwR2MwSU1lbGtjcWZiVFRSWi0xeGJMbXdCbXBCdVNyM1RVclNSOGNOclMwNHBlWlZvZnZvdUV6UDlYVmw5YUx4MUtoTmx4eVVCNDBYVzItSXhGVzZBajVOOXExdGV2bE5hUXlremxfWi1uN0VwWkg2aldwbzAxRFE?oc=5","date":"2026-02-19","type":"patent","source":"Bloomberg Law News","summary":"Takeda Drug Patent Suit Seeks to Block Qilu’s Copy of Livtencity - Bloomberg Law News","headline":"Takeda Drug Patent Suit Seeks to Block Qilu’s Copy of Livtencity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNRkV0WU02azhFV0gzNmJySmZQX1ZqMnNIY194aHAwbUFsbjIyUTJMZWR2VWU1Z09sakhRMnY5YWJFSW5rSURnTzJjMm1qaFZ5X2RpOU80WXRkMzhkTE1Jb1pQaWV6bG5qaElOcl9SZVgzZjNxNFAzRm9YOUtZbnNxcEIwbWkwM3RmaEgtZ3A0V01nS1RmY01NVURqMVdVSl9KYzJtY05hdm1IZUphazBZSGFyUEl3V0pLT0E?oc=5","date":"2026-01-13","type":"pipeline","source":"Investing.com","summary":"LG Chem to distribute Pacira’s EXPAREL in Asian-Pacific markets - Investing.com","headline":"LG Chem to distribute Pacira’s EXPAREL in Asian-Pacific markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNWGl1VWFnVC1EdTJnM2l6UHFlalpEbVRPTVppYTk5SnEyLTNOWWFwek42NGRNekNLTTJ0UlUtSGVBTzloV3hjN1hjeHBKa0VjYUdPcGFRNDB5TkU0ZTlSSTB1Z1V5bFBuTDd0NzFZRzBQZno4ZmlFeHROOXprc0YzWXA4Z1BhTHR5UVRIQVhtRzQ4M3VJT21YNkoxRTFreFhUaHloaUJBN3RnV1laMndJ?oc=5","date":"2026-01-09","type":"pipeline","source":"Life Sciences Intellectual Property Review","summary":"From migraine drugs to COVID vaccine spats, US lawsuits pile up - Life Sciences Intellectual Property Review","headline":"From migraine drugs to COVID vaccine spats, US lawsuits pile up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNa29wNHlUcHhYNFZaa083Yy1UV09sak9VcWsyOV9Dd2xobHZkSFZPNWpsc2NGdFhESzZBcHlKaGNXLWw2b2hZX3pZcUswRUlydFJzTEMzeFdDUmRnUVNfMG5LM0t3MWo5TVRHQlVOMzE4UEZFb2RIbkV0VE5EWExmZG9haW15Zl90R0F5TzY5cVpkbWNxMkdNMF9tQ0N1NDNIQWgxc3d1UHJvOXhkajQtSHJoZFdXOXRsNFZjajZUaldWal9uQUdXb3FDZWNHVFY0Njlxa0ttLTVtYlc5SHBmUEZNX3h5NlVoTnRBbV95V0RPT2psMlZEYlVrdlRvRVBPejdmejJKQVQzVmlMOEtDNzhB?oc=5","date":"2025-11-26","type":"patent","source":"GlobeNewswire","summary":"Pacira BioSciences Files EXPAREL® Patent Infringement - GlobeNewswire","headline":"Pacira BioSciences Files EXPAREL® Patent Infringement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNWUI1RGt2RmNnMVpIWWtlMjRXQTNMaFpYbThNUG9PcnZweHREcFQ3Z2ZmbEdJSjh1NkdWU1FHNFhyVDNaa1RndEE4bmdISmlfUkJNcGJQbVlvVzE4TUp3RXZhclA2bUlfaWJ2TzEtbTlLQU1ZTjlZR1d0alFRQ2Jjb2hPbUNob3NIOExXYjZyeEpIdHRpanNsR292RmJVZmY0UE5yalhFWk5lWnIxZ0xNdEE2cVU5SGpNa09iTlRqOXNWaE1RMGVSZzUyWFRyMjkzZXJtbi1R?oc=5","date":"2024-09-11","type":"pipeline","source":"Business Wire","summary":"China Top 100 Pesticide Enterprises Benchmark Report 2024 - ResearchAndMarkets.com - Business Wire","headline":"China Top 100 Pesticide Enterprises Benchmark Report 2024 - ResearchAndMarkets.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1TMmp5Y0JyWmJmS09UVlY2eEU0YThpSmYzZ01adTNlNms4MDV2d0J0ZzMtR29jaWFmS2QzNWRZbGlhTHhic2FXUTB4ckh4OHM0LXE0eUhrUmhvUUxFMmo3dl90UDVsRFFDUnozdndpRG9hSGQ3SHc?oc=5","date":"2022-08-11","type":"pipeline","source":"中国科技网","summary":"Hainan Aims to Spearhead Biomedical Industry Development - 中国科技网","headline":"Hainan Aims to Spearhead Biomedical Industry Development - 中国科技网","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE9FdUtmSjJnRkp6OEhLdXg3SDlFYmw2TmI2M0c2RGEzWnVhY184THBKZlNCVldDYk9GU0owaTZXcFp3QTJvVGlrbzBuejdSUTVDSl9IYndZZ3lrRm9iakwtcGE4TQ?oc=5","date":"2019-12-24","type":"earnings","source":"Straits Research","summary":"Oxaliplatin Market Size, Growth & Revenue Analysis Report | 2033 - Straits Research","headline":"Oxaliplatin Market Size, Growth & Revenue Analysis Report | 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQNG01OUZUaGZ0YjVLSEFGeXJVZWtfdmpOZkFCb254Nm1pVVE4Ynh2bUdvOENDU1BBbl81TkVaYS1MUlEzaXpnc0U3dDN3VmtKTUlZYzhpY1BmcDBrWXBOVWF0OEpucGxGRl9YV0R6VUlnd0w4Yk1SX2dka1dxTVdWWVUyOERfUnN3aEdTbTU3MzBsbnZLZGs4ZA?oc=5","date":"2019-06-13","type":"pipeline","source":"Pharmaceutical Technology","summary":"China pharmaceutical industry 2019: focus on Shandong and Jiangsu - Pharmaceutical Technology","headline":"China pharmaceutical industry 2019: focus on Shandong and Jiangsu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdmZlN2FoYjk2UlBZNG9JdW9uZENla095VUdGamZtQ0lNelVEOG55UnAtMERuME1GYjVRcFhkQ21Pc0ZobHczUXNVR0p3MldyZjhjSHB4ekJWUEpDX01keUh3N3dKUW9ILWhGTDN0OWhhNGhQZ0xyaHlSc05hbVBndWxFZDhMSktkR1Zla0kzZ3YzRnFtcHpYNXFUX1RoSDdSSmdmX2hJQmR1ckdnb3c?oc=5","date":"2016-02-10","type":"regulatory","source":"RAPS.org","summary":"US FDA Inspections in China: An Analysis of Form 483s from 2015 - RAPS.org","headline":"US FDA Inspections in China: An Analysis of Form 483s from 2015","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}